(Press-News.org) (Boston)—The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S. Some of this is due to social determinants of health such as disparities in health care access and quality of education, biases in testing and higher rates of AD risk factors such as cardiovascular disease and diabetes in those who identify as African American.
Although many studies have examined differences in gene expression (measure of the amount of protein encoded by a gene) in brain tissue from AD cases and controls in EA or mixed ancestry cohorts, the number of AA individuals in these studies was unspecified or too small to identify significant findings within this group alone.
In the largest AD study conducted in brain tissue from AA donors, researchers from Boston University Chobanian & Avedisian School of Medicine have identified many genes, a large portion of which had not previously been implicated in AD by other genetic studies, to be significantly more or less active in tissue from AD cases compared to controls. The most notable finding was a 1.5 fold higher level of expression of the ADAMTS2 gene in brain tissue from those with autopsy-confirmed AD.
Using solicited specimens from 14 NIH-funded AD Research Centers across the country, the researchers generated and evaluated gene expression data derived from post-mortem prefrontal cortex tissue from 207 AA brain donors (125 pathologically confirmed AD cases and 82 controls). They found the most significantly differentially expressed gene, ADAMTS2, was also the top-ranked gene in an independent study (medrxiv.org/content/10.1101/2024.11.12.24317218v1) conducted by the same research team in brain tissue from a much larger sample of EA individuals. In that study, they compared gene expression in brain tissue from pathologically confirmed AD cases who had clinical symptoms of AD prior to death with similarly pathologically diagnosed AD cases who were cognitively resilient.
“To our knowledge, this is the first time in similarly designed AD genetics studies that the most significant finding was the same in both white and African Americans,” said corresponding author Lindsay A. Farrer, PhD, chief of biomedical genetics at the school.
According to the researchers, this study is an important step in deciphering the genetic architecture and underlying mechanisms of AD risk in African Americans, considering evidence that nearly all the established AD risk variants are population-specific or have divergent frequencies across populations. “Although risk of AD in African Americans has been associated with variants in several genes, the overlap of genes showing association in in EA populations is modest, and even among the overlapping genes the particular variants involved and the size of the effect on AD risk usually differ,” explains Farrer. “The fact that expression of ADAMTS2 is significantly and substantially higher in brain tissue from both Whites and Blacks with AD not only points to a shared biological process leading to AD, but also elevates the priority of further research involving this gene which could determine its suitability as a potential therapeutic target.”
These findings appear online in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
This study was supported by National Institute of Health grants R01-AG048927, U01-AG058654, U54-AG052427, U19-AG068753, U01-AG062602, P30-AG072978, U01-081230, P01-AG003949, P30-AG062677, P30-AG062421; P30-AG 066507, P30-AG066511, P30-AG 072972, P30-AG066468, R01-AG072474, RF1-AG066107, U24-AG056270, P01-AG003949 , RF1-AG082339, RF1-NS118584, P30-AG072946; P01-AG003991, P30-AG066444, P01-AG026276, P30-AG066462, P30-AG072958, and P30-AG072978, and by Florida Department of Health awards 8AZ06 and 20A22. The funding sources had no role in study design; in the collection, analysis or interpretation of data; in the writing of this article; or in the decision to submit this article for publication.
Note to editors:
Mark Logue received grants from the NIH and Department of Veterans Affairs. Marla Gearing, Lee-Way Jin, Richard Mayeux, Richard Perrin, Shih-Hsiu Wang and Lindsay Farrer received grants from the NIH. Melissa Murray received grants from NIH, was a paid consultant for Biogen Pharmaceuticals, and served on committees for the Alzheimer’s Association and International Conference on Alzheimer’s and Parkinson’s Diseases. Thor Stein received grants from the NIH and Department of Veterans Affairs, and an honorarium from Brown University. Andrew Teich received grants from the NIH, a contract from Regeneron Pharmaceuticals and an honorarium from Ono Pharmaceuticals, owns stock in Ionis Pharmaceuticals and Biogen Pharmaceuticals, and served on committees for the Department of Defense and the Alzheimer’s Association. The effort of Katarnut Tobunluepop and Zihan Wang was supported by NIH grants. Benjamin Wolozin received grants from the NIH, consulting fees from Aquinnah Pharmaceuticals and Abbingworth Ventures, honoraria for several lectures, and owns stock and is Co-Founder and CSO of Aquinnah Pharmaceuticals Inc. Other authors have no competing interests to report.
END
First large-scale Alzheimer disease study in brain tissue from African American donors implicates roles for many novel genes
2025-10-08
ELSE PRESS RELEASES FROM THIS DATE:
In a nasal spray, gold “nanoparticles” deliver a targeted treatment to the brain. A potentially revolutionary approach to mental disorders and neurodegenerative diseases already has a patent
2025-10-08
In the form of a ‘nasal spray’, tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Cattolica Rome campus/Fondazione Policlinico Universitario A. Gemelli IRCCS, a new nanotechnological device for the treatment and prevention of neuropsychiatric and neurodegenerative diseases. These are lithium-loaded gold nanoparticles (lithium is already in clinical use for manic-depressive syndrome, but in oral formulation, not free from side effects) to combat neuropsychiatric diseases such as bipolar disorder, neurodegenerative diseases such as Alzheimer's disease, and brain infections such as those caused ...
Current and recommended diets in the USA have embedded forced labor risk
2025-10-08
Many Americans choose food based on cost and nutrition, but personal values, such as animal welfare and environmental concerns, also shape what ends up on our plates.
Now, researchers at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and the University of Nottingham Rights Lab and School of Geography have measured the risk of forced labor behind ingredients in recommended U.S. diets. By showing when healthy eating may come at the expense of exploited workers, the findings ...
AI breakthrough helps astronomers spot cosmic events with just a handful of examples
2025-10-08
A new study co-led by the University of Oxford and Google Cloud has shown how general-purpose AI can accurately classify real changes in the night sky — such as an exploding star, a black hole tearing apart a passing star, a fast-moving asteroid, or a brief stellar flare from a compact star system — and explain its reasoning, without the need for complex training.
Published today (8 October) in Nature Astronomy, the study by researchers from the University of Oxford, Google Cloud, and Radboud University demonstrates that a general-purpose ...
New vaccine shows promise against typhoid and invasive salmonella in first human trial
2025-10-08
Baltimore, MD — October 8, 2025 — Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.
Results were published today in the journal Nature Medicine.
The investigational Trivalent Salmonella Conjugate Vaccine (TSCV) includes sugar molecules taken from the outer coating of the Salmonella typhi bacteria that cause typhoid and ...
Engineered “natural killer” cells could help fight cancer
2025-10-08
CAMBRIDGE, MA -- One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be programmed to attack cancer cells.
MIT and Harvard Medical School researchers have now come up with a new way to engineer CAR-NK cells that makes them much less likely to be rejected by the patient’s immune system, which is a common drawback of this type of treatment.
The new advance may also make it easier to develop “off-the-shelf” ...
New 3D printing method ‘grows’ ultra-strong materials
2025-10-08
Vat photopolymerization is a 3D printing technique in which a light-sensitive resin is poured into a vat, and then selectively hardened into a desired shape using a laser or UV light. But this process is mostly used only with light-sensitive polymers, which limits its range of useful applications.
While some 3D printing methods have been developed to convert these printed polymers into tougher metals and ceramics, Daryl Yee, head of the Laboratory for the Chemistry of Materials and Manufacturing in EPFL’s School of Engineering, explains that materials produced with these techniques suffer from serious structural setbacks. “These materials tend to be ...
Lizard genetics provide new perspective on evolution
2025-10-08
Some colourful lizards and a mathematical formula from the finance sector have been used to build a new framework to model evolution.
Developed by Dr Simone Blomberg from The University of Queensland’s School of the Environment, it is the first mathematical model to combine short-term natural selection (microevolution) with the way species evolve over millions of years (macroevolution).
“There has been a big debate about whether microevolution can explain all of macroevolution,” Dr Blomberg said.
“We ...
Can a Stevia-derived sweetener improve hair loss treatment?
2025-10-08
Androgenetic alopecia is a common form of hair loss in both men and women—also called male pattern baldness and female pattern hair loss. Topical minoxidil is an approved treatment, but it has poor water solubility and skin permeability. New research in Advanced Healthcare Materials reveals that stevioside, a natural sweetener derived from the Stevia plant, can improve the drug’s absorption into the skin.
In a mouse model of alopecia, a dissolving patch formulation of stevioside with minoxidil effectively promoted hair follicles to enter the growth phase, leading to new hair development.
“Using stevioside to enhance minoxidil delivery represents ...
Method to assess the status of wild reindeer may help with conservation efforts
2025-10-08
Reindeer are iconic in the Arctic and subarctic, but their numbers are declining. As described in research published in Wildlife Monographs, investigators developed an environmental quality standard, or norm, for reindeer populations to evaluate their overall status, and gave them simple status categories of poor, medium, and good.
The standard has indices for the status of population performance, lichen resources, and human-related habitat loss and fragmentation. The scientists implemented their environmental quality standard for 10 national and 14 smaller wild reindeer areas in Norway. They found that only 1 population had a good status; 11 populations ...
Do imported cut flowers spread livestock viruses?
2025-10-08
A study in Medical and Veterinary Entomology investigated whether Culicoides biting midges—tiny insects that can carry serious livestock viruses—are being accidentally exported from Africa to Europe in shipments of cut flowers.
Although researchers did detect small numbers of these insects near and inside greenhouses on a Kenyan flower farm, they found none in packaging or transport areas. This suggests that the risk of midges being shipped with flowers is very low, but not zero.
Given that northern Europe has experienced several unexpected outbreaks of livestock diseases spread by midges in recent years, the findings highlight the need ...